神阙穴隔药灸对接受体外受精-胚胎移植的反复种植失败患者妊娠结局的有效性:随机对照试验研究方案
本研究为随机对照试验方案,计划从山东中医药大学附属医院招募210例拟行冻融胚胎移植的反复种植失败患者,按1:1随机分为治疗组和对照组。治疗组在连续3个月经周期接受每周一次的神阙穴隔药灸,对照组不接受干预;第4个月经周期所有患者均行人工周期准备内膜后行冻融胚胎移植,随访3个月。主要结局为持续妊娠率,次要结局包括内膜类型、双侧子宫动脉阻力指数、搏动指数、内膜血流、血清雌二醇、孕酮、生化妊娠率、种植率和临床妊娠率。
要点
- 神阙穴隔药灸在反复种植失败患者中的应用尚未见报道,本研究旨在评估其有效性和安全性。
- 治疗组每周一次神阙穴隔药灸,连续3个月经周期;对照组3个月经周期不干预。
- 主要结局为持续妊娠率,次要结局涵盖内膜类型、血流指标、激素水平及多项妊娠率。
核心结论
- 若结果显示神阙穴隔药灸可改善反复种植失败患者的体外受精-胚胎移植结局,则将在临床实践中推荐。
研究设计与样本
- 随机对照试验方案,计划从山东中医药大学附属医院招募210例拟行冻融胚胎移植的反复种植失败患者,按1:1随机分为治疗组和对照组。
主要发现
- 治疗组每周一次神阙穴隔药灸,连续3个月经周期;对照组3个月经周期不干预;第4个月经周期所有患者行人工周期准备内膜后行冻融胚胎移植,随访3个月。
- 主要结局为持续妊娠率,与对照组比较。
- 次要结局包括内膜类型、双侧子宫动脉阻力指数、搏动指数、内膜血流、血清雌二醇、孕酮、生化妊娠率、种植率和临床妊娠率。
关键数值与推荐
- 反复种植失败的发生率通常介于5%至10%之间。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Recurrent implantation failure (RIF) in the majority of patients undergoing in vitro fertilization and embryo transfer (IVF-ET) is caused by various factors such as maternal age, embryo quality, endometrial receptivity (ER), and immunity. The incidence of RIF is usually between 5 and 10%. Previous studies have shown that herb-partitioned moxibustion on the navel is one of the treatment methods of acupuncture with a positive effect on pregnancy. However, its application in the treatment of RIF has not been reported. Therefore, this study aims to evaluate the effectiveness and safeness of herb-partitioned moxibustion on the navel in improving the outcome of frozen embryo transfer (FET) in patients with RIF. METHODS: This study conducts a randomized controlled trial (RCT). It is planned to recruit 210 patients undergoing RIF for FET from Affiliated Hospital of Shandong University of Traditional Chinese Medicine and randomly divide them into the treatment group and the control group in a ratio of 1:1. The patient of the treatment group will be treated with herb-partitioned moxibustion on the navel once a week for three consecutive menstrual cycles. No intervention will be used in the control group for 3 menstrual cycles. In the fourth menstrual cycle, all patients will undergo artificial cycle to prepare the endometrium for FET. The pregnancy outcomes will be recorded after a 3-month follow-up. Primary outcome will be assessed as the ongoing pregnancy rate compared with the control group. Secondary outcomes include the endometrial type, resistance index (RI), pulsatility index (PI) of the bilateral uterine artery, endometrial blood flow, serum estradiol (E2), progesterone (P), biochemical pregnancy rate, implantation rate, and clinical pregnancy rate. DISCUSSION: If the results show that the herb-partitioned moxibustion on the navel can improve IVF-ET outcomes in patients with RIF, it will be recommended in clinical practice. TRIAL REGISTRATION: Chinese Clinical Trial Registry (ChiCTR) ChiCTR2100043954 . Registered on 8 July 2021.
引用
- Xia Q, Gao S, Song J, et al. Effectiveness of herb-partitioned moxibustion on the navel for pregnancy outcomes in patients with recurrent implantation failure undergoing in vitro fertilization and embryo transfer: a study protocol for a randomized controlled trial. Trials. 2022. PMID: 35292074. doi:10.1186/s13063-022-06156-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。